{"id":795555,"date":"2024-12-17T13:35:21","date_gmt":"2024-12-17T18:35:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"modified":"2024-12-17T13:35:21","modified_gmt":"2024-12-17T18:35:21","slug":"tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WARREN, N.J., Dec.  17, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qfhckuWGMs2i37gCk0CkqZZdUQl036aHMyvjF6g8zvwL-1cQ2YxfQm3iAy7WiMOTNDGc01QH_ttRZ98y7-VVeA==\" rel=\"nofollow\" target=\"_blank\">Tevogen Bio<\/a> (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WW5zANloeWk29R8WpI-FJ5Ik_hULHNZafDOwBdaVItF7g2ahxv_1Mo9Qur5M2JDDZjSPBhFMJyhiReAa8Pzz-TN6gNMWz6j1FJtqWJmRDDY=\" rel=\"nofollow\" target=\"_blank\">TVGN<\/a>), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that it will host a compelling panel discussion, \u201cPioneering the Economics of Health: Balancing Access and Outcomes,\u201d during the 43rd Annual J.P. Morgan Healthcare Conference.<\/p>\n<p>This panel will bring together global thought leaders to examine the critical interdependencies of the healthcare ecosystem, a dynamic interplay between patient accessibility, medical innovation, reimbursement mechanism and health policy often overlooked when only considering a singular silo of it. The discussion will focus on:<\/p>\n<ul>\n<li>The challenges and opportunities presented by U.S. leadership in healthcare innovation, particularly in balancing rising costs and value delivery.<\/li>\n<li>The impact of cost-containment measures, including the Inflation Reduction Act, on drug development and patient access.<\/li>\n<li>The implications of the new administration\u2019s approach to U.S. healthcare for global markets and business model of medical innovation industry.<\/li>\n<\/ul>\n<p>Panelists consist of Senior Partner at Simon-Kucher; Former Acting Under Secretary for Health, Department of Veterans Affairs and Former Commissioner, New Jersey Department of Health; Principal, Rubix Health, and Senior Fellow, Tufts Center for Evaluation of Value and Risk in Health and Venture Mentor, Johns Hopkins Tech Ventures, Former CMS Chief Clinical Officer and Director of The Office of Clinical Standards; Managing Director for Risk Advisory Services, Veritas; CEO of Tevogen Bio; CIO and Head of AI at Tevogen Bio.<\/p>\n<p>\n        <strong>Event Details<\/strong>\n      <\/p>\n<p>\n        <strong>Date:<\/strong><br \/>\n        <br \/>Monday, January 13, 2025<\/p>\n<p>\n        <strong>Location:<\/strong><br \/>\n        <br \/>Marines\u2019 Memorial Club &amp; Hotel 609 Sutter St, San Francisco, CA 94102, United States<\/p>\n<p>\n        <strong>Time (PST):<\/strong><br \/>\n        <br \/>3:15 PM \u2013 4:00 PM \u2013 Pioneering the Economics of Health: Balancing Access and Outcomes<br \/>4:00 PM \u2013 6:00 PM \u2013 Reception and Cocktails<\/p>\n<p>For inquiries regarding additional event details, please contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D1iahvIzqQGJmN-8EpoNdcotXVw3XD2yDls5-jH0EMgAmXCPs5zGcmh7BTJ5mIyvoKanDvE-hpIP9YUJ1WGUTQ1d7HyQ8zvIlS7t7ok7NWBfFJD0Or9uXmKeMwhGEoVD\" rel=\"nofollow\" target=\"_blank\">communications@tevogen.com<\/a>.<\/p>\n<p>\n        <strong>About Tevogen Bio<\/strong>\n      <\/p>\n<p>Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature\u2019s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence.<\/p>\n<p>Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen\u2019s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Tevogen Bio Communications<br \/>T: 1 877 TEVOGEN, Ext 701 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FuCI6n068sSwRrRe2vVQpovsYqLp4K2ZM1QxT_N3lvRuMqg1fTAvuzlVe7a76qIV2RYeys2K-51Rr81h2waEb4NzAwnY8LXWMXPLhOwTfgT-EnzZ-g3eC-1hoe4LPKAo\" rel=\"nofollow\" target=\"_blank\">Communications@Tevogen.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDg1NjE4OTEtZTdiMy00YzNmLWE0ZmUtYzMyOGNlMDhlODgwLTEzMDE0Njc=\/tiny\/Tevogen-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that it will host a compelling panel discussion, \u201cPioneering the Economics of Health: Balancing Access and Outcomes,\u201d during the 43rd Annual J.P. Morgan Healthcare Conference. This panel will bring together global thought leaders to examine the critical interdependencies of the healthcare ecosystem, a dynamic interplay between patient accessibility, medical innovation, reimbursement mechanism and health policy often overlooked when only considering a singular silo of it. The discussion will focus on: The challenges and opportunities presented by U.S. leadership in healthcare innovation, particularly &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-795555","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that it will host a compelling panel discussion, \u201cPioneering the Economics of Health: Balancing Access and Outcomes,\u201d during the 43rd Annual J.P. Morgan Healthcare Conference. This panel will bring together global thought leaders to examine the critical interdependencies of the healthcare ecosystem, a dynamic interplay between patient accessibility, medical innovation, reimbursement mechanism and health policy often overlooked when only considering a singular silo of it. The discussion will focus on: The challenges and opportunities presented by U.S. leadership in healthcare innovation, particularly &hellip; Continue reading &quot;Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-17T18:35:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference\",\"datePublished\":\"2024-12-17T18:35:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":503,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\",\"datePublished\":\"2024-12-17T18:35:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that it will host a compelling panel discussion, \u201cPioneering the Economics of Health: Balancing Access and Outcomes,\u201d during the 43rd Annual J.P. Morgan Healthcare Conference. This panel will bring together global thought leaders to examine the critical interdependencies of the healthcare ecosystem, a dynamic interplay between patient accessibility, medical innovation, reimbursement mechanism and health policy often overlooked when only considering a singular silo of it. The discussion will focus on: The challenges and opportunities presented by U.S. leadership in healthcare innovation, particularly &hellip; Continue reading \"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-17T18:35:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference","datePublished":"2024-12-17T18:35:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"wordCount":503,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","name":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=","datePublished":"2024-12-17T18:35:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMDY3NCM2NjQxNjY0IzIyODk5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-pioneering-the-economics-of-health-balancing-access-and-outcomes-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tevogen Bio to Host Panel \u201cPioneering the Economics of Health: Balancing Access and Outcomes\u201d During the 43rd Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=795555"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/795555\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=795555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=795555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=795555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}